Prognostic biomarkers for response to vascular endothelial growth factor-targeted therapy for renal cell carcinoma Journal Article

   

Authors:	Winer, A. G.; Motzer, R. J.; Hakimi, A. A.
Article Title:	Prognostic biomarkers for response to vascular endothelial growth factor-targeted therapy for renal cell carcinoma
Keywords:	platelet derived growth factor; vasculotropin; vasculotropin receptor 3; treatment response; unclassified drug; single nucleotide polymorphism; review; sorafenib; bevacizumab; sunitinib; disease marker; antineoplastic agent; inflammation; vasculotropin receptor 2; prediction; renal cell carcinoma; kidney carcinoma; germ line; cytokine; carbonate dehydratase ix; biomarker; laboratory test; pazopanib; targeted therapy; axitinib; tyrosine kinase inhibitor; von hippel lindau protein; genetic polymorphism; vegf; angiogenic factor; molecularly targeted therapy; hypoxia inducible factor 2alpha; cancer prognosis; human; priority journal; valatenib; von hippel lindau gene
Journal Title:	Urologic Clinics of North America
Volume:	43
Issue:	1
ISSN:	0094-0143
Publisher:	W.B. Saunders Co-Elsevier Inc.
Date Published:	2016-02-01
Start Page:	95
End Page:	104
Language:	English
DOI:	10.1016/j.ucl.2015.08.009
PROVIDER:	scopus
PUBMED:	26614032
PMCID:	PMC4864362
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84952936665&partnerID=40&md5=aef1d54c38292ca0eea02a9a5971d090
Notes:	Review -- Export Date: 3 February 2016 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/87889